Ocrevus Cupones y Precios - Rx.com

Ocrevus (ocrelizumab) is a brand-name infused medication for relapsing and primary progressive multiple sclerosis, and if you're comparing an Ocrevus coupon against the manufacturer's savings program, it helps to know how the two actually work before your next infusion — enter your ZIP above to see today's price at pharmacies and infusion centers near you.

What Is Ocrevus and How Does It Work?

Ocrevus is the brand name for ocrelizumab, a monoclonal antibody that targets and depletes CD20-positive B-cells, a type of immune cell involved in the nerve damage seen in multiple sclerosis (MS). It's FDA-approved for adults with relapsing forms of MS — including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease — as well as for primary progressive MS. It's also approved for relapsing-remitting MS in children 10 and older who weigh at least 25 kg.

Ocrevus is given as an intravenous (IV) infusion at a doctor's office or infusion center, starting with two initial doses, then continuing on a twice-a-year schedule. A newer option, Ocrevus Zunovo, combines ocrelizumab with hyaluronidase in a subcutaneous injection that takes about 10 minutes, offered as an alternative to the IV infusion.

Ocrevus Cost: Manufacturer Savings Card vs. Rx.com Coupon

Because Ocrevus is a brand-name biologic with no generic version, cost is a major factor for most patients. Genentech, the manufacturer, offers an official patient support program (search "Ocrevus financial support" on genentech.com or ocrevus.com) that can lower out-of-pocket costs — but like most manufacturer savings cards, it's generally limited to patients with commercial (private) insurance, and terms, eligibility, and any dollar limits vary and can change, so confirm current details directly with the program.

If you're uninsured, on Medicare, or your manufacturer card is declined at the pharmacy or infusion billing office, an Rx.com cash coupon can still be used to shop and compare pricing — it doesn't have the commercial-insurance restriction that manufacturer cards typically carry. Genentech's program materials also reference patient assistance options for those who qualify based on income or insurance status, which is worth asking about if cost is a barrier. Enter your ZIP above to compare current pricing near you.

Ocrevus Alternatives and Comparisons

Ocrevus is one of several disease-modifying therapies (DMTs) used for relapsing forms of MS, and the right choice depends on disease activity, administration preference, and a neurologist's recommendation. Options in the same general category of MS treatment include Tysabri (natalizumab, an infused therapy), Kesimpta (ofatumumab, a self-injected B-cell therapy), and oral options like Gilenya (fingolimod), Tecfidera (dimethyl fumarate), and Aubagio (teriflunomide).

Rituxan (rituximab) is a related anti-CD20 antibody that is sometimes used off-label in MS, though it isn't FDA-approved for that use. There is no generic or biosimilar version of ocrelizumab currently available, so switching between these options is a decision to make with your neurologist based on effectiveness and administration, not price alone.

Ocrevus Safety Information and Side Effects

Ocrevus carries several important warnings covering two main risk areas. First, infusion-related reactions are common — reported in roughly 34-40% of patients — which is why premedication with a corticosteroid, and often an antihistamine, is required before each dose. Second, Ocrevus increases the risk of infections, including possible reactivation of hepatitis B (screening is required before starting treatment) and progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. It should not be used in anyone with an active hepatitis B infection or a history of a life-threatening infusion reaction to ocrelizumab.

The label also notes an increased risk of malignancy, including breast cancer, associated with long-term B-cell depletion. This is general information, not medical advice — talk with your prescribing doctor about your personal risk factors and what monitoring is recommended while on Ocrevus.